{"id":"W4385237581","doi":"10.1136/lupus-2022-000890","title":"Improving resource utilisation in SLE drug development through innovative trial design","year":2023,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"EMD Serono; Genentech; National Institutes of Health; Idorsia Pharmaceuticals; Acceleron; Lupus Research Alliance; Alexion Pharmaceuticals; Celgene; Biogen; Mallinckrodt Pharmaceuticals; Gilead Sciences; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Drug development; Drug; Resource (disambiguation); Intensive care medicine; Pharmacology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01424893,0.0007120219,0.003183529,0.002450414,0.0003421195,0.00006511359,0.001141153,0.0003380812,0.00009042808],"category_scores_gemma":[0.009176209,0.0004715383,0.0001408465,0.01293933,0.001525874,0.0003322748,0.0003871324,0.001260464,0.0002642582],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002945851,"about_ca_system_score_gemma":0.008989755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002617764,"about_ca_topic_score_gemma":0.00003968658,"domain_scores_codex":[0.990489,0.0005901078,0.002463365,0.001569667,0.003554383,0.001333488],"domain_scores_gemma":[0.9953374,0.001607524,0.0009360194,0.001124606,0.0006455494,0.0003488766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002494456,0.000236171,0.0002040819,0.04761725,0.0001483248,0.0005594046,0.0404425,0.000004285308,0.0001122615,0.0002973008,0.01613771,0.8917463],"study_design_scores_gemma":[0.0202061,0.0006104189,0.000002805672,0.1102555,0.0002206735,0.0027987,0.005253118,0.0001776616,0.00006981553,0.00005147891,0.8597606,0.0005931681],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001047037,0.9790057,0.001257585,0.0004373497,0.004325435,0.01065085,0.000004043999,0.0002834337,0.002988586],"genre_scores_gemma":[0.0001558737,0.9720759,0.002731375,0.0002124765,0.001750569,0.001670787,0.0001570102,0.0002231628,0.02102281],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8911531,"threshold_uncertainty_score":0.9997736,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.205565501183303,"score_gpt":0.4264593646459777,"score_spread":0.2208938634626747,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}